Close
Close
Treatment Database
autologous chimeric antigen receptor (CAR) T cells targeting intercellular adhesion molecule-1 (ICAM-1)
Trade Name not avaiable
Orphan Indication Anaplastic thyroid cancer, medullary thyroid cancer, and recurrent or metastatic follicular or papillary thyroid cancer
USA Market Approval
USA Designation Date 09-04-2019
Sponsor AffyImmune Therapeutics, Inc.
12 Michigan Dr.
Natick, Massachusetts, 01760
More about Medullary thyroid cancer
Free Newsletter
Treatment News
Related Videos
by Abidemi Uruejoma
9,841 views